glp-1 in pregnancy GLP1-RAs: The New Era of Diabetes and Weight Loss Management, FAQs and Lactation GLP-1 weight-loss drugs pose hidden

Gastrointestinal manifestations of diabetes mellitus Gastrointestinal manifestations in people with type 1 or type 2 diabetes are common, varied and observed throughout the gastrointestinal tract

Navigating the Gut Buffet: Control of Polysaccharide Utilization in Bacteroides spp

Clinical evidence regarding the benefits of tirzepatide in HFpEF patients The GIP/GLP-1 dual receptor agonist tirzepatide has been approved for the treatment of obesity and T2DM

Available since 2012, Qsymia is an FDA-approved medication for adults with a BMI of 30 or higher, or 27 with weight-related conditions like hypertension or diabetes

Over the past two decades, advances in our understanding of gut-derived hormonesparticularly incretinshave reshaped how we treat these conditions